We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPKI
1451
NPK International
NPKI
$1.14B
-19,470
Closed -$113K
SGI
1452
Somnigroup International
SGI
$13.7B
-11,068
Closed -$663K
QVCGA
1453
DELISTED
QVC Group Inc Series A
QVCGA
-5,527
Closed -$55.6K
WHWK
1454
Whitehawk Therapeutics
WHWK
$271M
-10,197
Closed -$18.2K
LGF.A
1455
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
-22,539
Closed -$199K
EVBN
1456
DELISTED
Evans Bancorp Inc
EVBN
-63,266
Closed -$2.47M
WMPN
1457
DELISTED
William Penn Bancorporation Common Stock
WMPN
-45,376
Closed -$496K
BERY
1458
DELISTED
Berry Global Group, Inc.
BERY
-15,919
Closed -$1.11M
BECN
1459
DELISTED
Beacon Roofing Supply, Inc.
BECN
-46,816
Closed -$5.79M
ENFN
1460
DELISTED
Enfusion, Inc.
ENFN
-255,622
Closed -$2.85M
FNA
1461
DELISTED
Paragon 28, Inc.
FNA
-147,024
Closed -$1.92M
CMRX
1462
DELISTED
Chimerix, Inc.
CMRX
-313,846
Closed -$2.67M
PDCO
1463
DELISTED
Patterson Companies, Inc.
PDCO
-49,994
Closed -$1.56M
ML.WS
1464
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
-1,500,000
Closed -$398K
PYCR
1465
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
-41,096
Closed -$922K
ATSG
1466
DELISTED
Air Transport Services Group
ATSG
-185,940
Closed -$4.17M
ACCD
1467
DELISTED
Accolade Inc
ACCD
-64,229
Closed -$448K
LGTY
1468
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
-198,138
Closed -$2.83M
NVRO
1469
DELISTED
NEVRO CORP.
NVRO
-525,759
Closed -$3.07M
ITCI
1470
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-79,142
Closed -$10.4M
ITCI
1471
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-2,900
Closed -$383K
DM
1472
DELISTED
Desktop Metal, Inc.
DM
-203,252
Closed -$998K
VOXX
1473
DELISTED
VOXX International Corporation Class A
VOXX
-307,202
Closed -$2.3M
SASR
1474
DELISTED
Sandy Spring Bancorp Inc
SASR
-24,408
Closed -$682K
VBFC
1475
DELISTED
Village Bank and Trust Financial Corp.
VBFC
-21,431
Closed -$1.72M

Similar funds

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.